Recent performance snapshot Biogen (BIIB) shares closed at US$171.59, with performance mixed across recent periods. The stock shows a 1 day return of about a 1% decline, a 4.4% gain over the past week ...
StockStory.org on MSN
3 reasons to sell BIIB and 1 stock to buy instead
The past six months have been a windfall for Biogen’s shareholders. The company’s stock price has jumped 41.7%, setting a new ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
InvestorsHub on MSN
Biogen’s Q4 preliminary EPS misses market expectations
Biogen (NASDAQ:BIIB) said its preliminary adjusted earnings per share for the fourth quarter of 2025 are expected to be about ...
Investors in Biogen Inc (Symbol: BIIB) saw new options become available today, for the December 19th expiration. One of the key data points that goes into the price an option buyer is willing to pay, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results